Henry Butt
Henry Butt, MSc, PhD, is the Director of Bioscreen (a laboratory specializing in fecal microbial analysis) and a researcher in Newcastle, Australia.
Contents
Books[edit | edit source]
- 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by Christopher W. Armstrong, Neil R. McGregor, Henry L. Butt, and Paul R. Gooley[1]
Notable studies[edit | edit source]
- 2018, Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons[2] (Full Text) (Correction)
- 2017, Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review[3] (Full Text)
- 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome[4]
- 2016, Widespread pain and altered renal function in ME/CFS patients[5]
- 2016, Support for the Microgenderome: Associations in a Human Clinical Population[6] (Full Text)
- 2015, Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study (Jackson ML, Henry Butt, Ball M, Lewis DP, Bruck D)
- 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients[7]
- 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome [8]
- 2009, Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome[9]
- 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome[10]
- 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study[11]
- 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome[12]
- 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome [13]
- 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome[14]
- 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome
- 1996, Preliminary determination of a molecular basis of chronic fatigue syndrome
Clinic location[edit | edit source]
Newcastle, Australia.
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ Christopher W. Armstrong, Neil R. McGregor, Henry L. Butt, and Paul R. Gooley. (2014) Metabolism in Chronic Fatigue Syndrome In Gregory S. Makowski (Editor), Advances in Clinical Chemistry, Vol. 66, (pp 121-172). Burlington: Academic Press, Elsevier Inc. Retrieved from http://www.academia.edu/11578244/CHAPTER_FIVE_Metabolism_in_Chronic_Fatigue_Syndrome
- ↑ Wallis, Amy; Ball, Michelle; Butt, Henry L; Lewis, Donald P; McKechnie, Sandra; Paull, Phillip; Jaa-Kwee, Amber; Bruck, Dorothy (2018), "Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons", Journal of Translational Medicine, 16 (1): 24, doi:10.1186/s12967-018-1392-z
- ↑ Wallis, Amy; Ball, Michelle; McKechnie, Sandra; Butt, Henry L; Lewis, Donald P; Bruck, Dorothy (2017), "Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review", Journal of Translational Medicine, 2017 (15): 129, doi:10.1186/s12967-017-1229-1
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2017), "The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome", Metabolomics, 13 (1), doi:10.1007/s11306-016-1145-z
- ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2016), "Widespread pain and altered renal function in ME/CFS patients", Fatigue: Biomedicine, Health & Behavior, 4 (3): 132-145, doi:10.1080/21641846.2016.1207400
- ↑ Wallis, Amy; Butt, Henry L; Ball, Michelle; Lewis, Donald P; Bruck, Dorothy (13 Jan 2016), "Support for the Microgenderome: Associations in a Human Clinical Population", Scientific Reports, volume 6; article 19171, doi:10.1038/srep19171, PMID 26757840
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2015), "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients", Metabolomics, 11 (6): 1626–1639, doi:10.1007/s11306-015-0816-5
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Sheedy, John R.; Buttfield, Ian; Butt, Henry L.; Gooley, Paul R. (2012), "NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome", Clinica Chimica Acta, 413 (19–20): 1525–1531, doi:10.1016/j.cca.2012.06.022
- ↑ Sheedy, John R.; Wettenhall, Richard E.H.; Scanlon, Denis; Gooley, Paul R.; Lewis, Donald P.; McGregor, Neil; Stapleton, David; Butt, Henry L.; De Meirleir, Kenny L. (2009), "Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome", In Vivo, 23 (4): 621-628, PMID 19567398
- ↑ Richards, RS; Roberts, TK; McGregor, NR; Dunstan, RH; Butt, HL (2000), "Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome", Redox Report, 5 (1): 35-41, doi:10.1179/rer.2000.5.1.35, PMID 10905542
- ↑ R. S. Richards, T. K. Roberts, D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 23-35. http://dx.doi.org/10.1300/J092v06n01_03
- ↑ R. S. Richards, T. K. Roberts, D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 37-46. http://dx.doi.org/10.1300/J092v06n01_04
- ↑ Timothy K. Roberts, Neil R. McGregor, R. Hugh Dunstan, Mark Donohoe, Raymond N. Murdoch, D. Hope, S. Zhang, Henry L. Butt, Jennifer A. Watkins, and Warren G. Taylor. (1998). Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 4, Iss. 4, pp. 51-65. http://dx.doi.org/10.1300/J092v04n04_05
- ↑ N.R. McGregor, R.H. Dunstan, H.L. Butt, T.K. Roberts, I.J. Klineberg, and M. Zerbes. (1997). A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 17-37. http://dx.doi.org/10.1300/J092v03n01_03
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
